Qaytona is free while it's in beta — Get started

Ingredients

Lactobacillus gasseri

L. gasseri

Snapshot

IndicationsContraindications
  • Irritable bowel syndrome1, 2
  • Functional constipation3
  • Vaginal microbiota support4
  • Stress-related symptoms5, 6
  • Sleep quality5
  • Abdominal adiposity7
  • Functional constipation3
  • Helicobacter pylori suppression8, 9
  • Not intended for children10
  • Anticipated surgery10
  • Milk, soy, or wheat allergy10

Lactobacillus gasseri is a lactic acid bacterium that colonizes the human gut and vagina, with strain-specific probiotic effects that act through mucosal adhesion, antimicrobial activity, and immune modulation11. Supplementation is used for gut function, including abdominal pain in irritable bowel syndrome (IBS) and functional constipation1–3. It is also used for vaginal microbiota support, for stress-related symptoms and sleep, and for abdominal adiposity.

Evidence is strain-specific and varies by use. The IBS data include an uncontrolled multicenter study that its authors say needs placebo-controlled confirmation. Weight results are split: a fermented-milk strain reduced abdominal fat7, while another strain produced no significant between-group weight change12. In women recovering from bacterial vaginosis, oral strains did not improve cure rates13. In healthy women, a 2025 randomized trial found an orally taken strain in vaginal swabs, with no treatment outcome tested. Products are mostly capsules, and some trials use heat-inactivated cells; see Form comparison.

Case reports describe bacteremia and liver abscess from Lactobacillus gasseri, including in a patient with diabetes and prior abdominal surgery14. A high-dose trial in healthy adults identified no safety concerns15. Per product labels, those taking medication or with a medical condition are told to consult a healthcare provider first10.

Last updated October 16, 2026. Read how we make monographs.

In the full monograph

50 sources, 36 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Lactobacillus gasseri LA806 Supplementation in Patients with Irritable Bowel Syndrome: A Multicenter Study.pubmed.ncbi.nlm.nih.govAit Abdellah, Scanzi, Gal et al. · Journal of clinical medicine · 2022 · Pubmed
  2. 2The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome.pubmed.ncbi.nlm.nih.govNobutani, Sawada, Fujiwara et al. · Journal of applied microbiology · 2017 · Pubmed
  3. 3Therapeutic Value of Lactobacillus gasseri 345A in Chronic Constipation.pubmed.ncbi.nlm.nih.govRoos, Dahlgren, Mao et al. · Neurogastroenterology and motility · 2025 · Pubmed
  4. 4Lactobacillus gasseri CECT 30648 shows probiotic characteristics and colonizes the vagina of healthy women after oral administration.pubmed.ncbi.nlm.nih.govPerez, Armengol, Del Casale et al. · Microbiology spectrum · 2025 · Pubmed
  5. 5Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study.pubmed.ncbi.nlm.nih.govNishida, Sawada, Kuwano et al. · Nutrients · 2019 · Pubmed
  6. 6Para-psychobiotic Lactobacillus gasseri CP2305 ameliorates stress-related symptoms and sleep quality.pubmed.ncbi.nlm.nih.govNishida, Sawada, Kawai et al. · Journal of applied microbiology · 2017 · Pubmed
  7. 7Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.pubmed.ncbi.nlm.nih.govKadooka, Sato, Imaizumi et al. · European journal of clinical nutrition · 2010 · Pubmed
  8. 8Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy.pubmed.ncbi.nlm.nih.govDeguchi, Nakaminami, Rimbara et al. · Journal of gastroenterology and hepatology · 2012 · Pubmed
  9. 9Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.pubmed.ncbi.nlm.nih.govSuzuki, Masui, Nakamura et al. · Digestion · 2017 · Pubmed
  10. 10US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
  11. 11Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health.pubmed.ncbi.nlm.nih.govSelle, Klaenhammer · FEMS microbiology reviews · 2013 · Pubmed
  12. 12Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial.pubmed.ncbi.nlm.nih.govJung, Lee, Kang et al. · Korean journal of family medicine · 2013 · Pubmed
  13. 13Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis.pubmed.ncbi.nlm.nih.govQi, Fan, Fang et al. · Frontiers in immunology · 2023 · Pubmed
  14. 14Lactobacillus gasseri liver abscess and bacteremia: a case report.pubmed.ncbi.nlm.nih.govRamos-Coria, Canto-Losa, Carrillo-Vázquez et al. · BMC infectious diseases · 2021 · Pubmed
  15. 15Evaluation of the safety of high-dose Lactobacillus gasseri CP2305 supplementation in healthy adults: A randomized, double-blind, placebo-controlled study.pubmed.ncbi.nlm.nih.govFuchida, Sawada, Hirota et al. · Toxicology reports · 2026 · Pubmed